Cancer Survivorship Care in the United States at Facilities Accredited by the Commission on Cancer.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 Jul 2024
Historique:
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: epublish

Résumé

Since 2021, American College of Surgeons Commission on Cancer (CoC) accreditation standards require providing a survivorship program for patients with adult-onset cancer treated with curative intent. Since more than 70% of all patients with cancer in the US are treated at CoC-accredited facilities, this presents an opportunity for a landscape analysis of survivorship care availability. To determine the prevalence, types, and outcomes of cancer survivorship services at CoC-accredited facilities. This survey study used an anonymous, online, cross-sectional survey conducted from May 4 to 25, 2023. Participants were CoC-accredited facilities in the US representing diverse CoC program categories, institutional characteristics, geographic regions, and practice types. Department of Veterans Affairs cancer programs were excluded due to data usage restrictions. Data were analyzed from July to October 2023. CoC Survivorship Standard 4.8 was released in October 2019 and programs were expected to adhere to the Standard beginning January 1, 2021. Questions included self-reported survivorship program characteristics, availability of services aligned to CoC Survivorship Standard 4.8, and perceived program impacts. Response frequencies and proportions were determined in aggregate and by CoC program category. There were 1400 eligible programs, and 384 programs participated (27.4% response rate). All regions and eligible program categories were represented, and most had analytic caseloads of 500 to 4999 patients in 2021. Most survivorship program personnel included nurses (334 programs [87.0%]) and social workers (278 programs [72.4%]), while physical (180 programs [46.9%]) and occupational (87 programs [22.7%]) therapists were less common. Services most endorsed as available for all survivors were screening for new cancers (330 programs [87.5%]), nutritional counseling (325 programs [85.3%]), and referrals to specialists (320 programs [84.7%]), while treatment summaries (242 programs [64.7%]), and survivorship care plans (173 programs [43.0%]), sexual health (217 programs [57.3%]), and fertility (214 programs [56.9%]) were less common. Survivorship services were usually delivered by cancer treatment teams (243 programs [63.3%]) rather than specialized survivorship clinics (120 programs [31.3%]). For resources needed, additional advanced practice clinicians with dedicated survivorship effort (205 programs [53.4%]) and electronic health record enhancements (185 programs [48.2%]) were most endorsed. Lack of referrals and low patient awareness were endorsed as the primary barriers. A total of 335 programs (87.2%) agreed that Survivorship Standard 4.8 helped advance their programs. These findings of this survey study of CoC-accredited programs establish a benchmark for survivorship care delivery in the US, identify gaps in specific services and opportunities for intervention, contribute to longitudinal reevaluation for tracking progress nationally, and suggest the value of survivorship care standards.

Identifiants

pubmed: 38958979
pii: 2820708
doi: 10.1001/jamanetworkopen.2024.18736
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2418736

Auteurs

Julia Stal (J)

Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles.
Cancer Research Program, American College of Surgeons, Chicago, Illinois.

Kimberly A Miller (KA)

Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles.
Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.
USC Norris Comprehensive Cancer Center, Los Angeles, California.

Timothy W Mullett (TW)

Markey Cancer Center, Cancer Prevention and Control Program, University of Kentucky, Lexington.
Department of Surgery, College of Medicine, University of Kentucky, Lexington.
Commission on Cancer, American College of Surgeons, Chicago, Illinois.

Judy C Boughey (JC)

Cancer Research Program, American College of Surgeons, Chicago, Illinois.
Department of Surgery, Mayo Clinic, Rochester, Minnesota.

Amanda B Francescatti (AB)

Cancer Research Program, American College of Surgeons, Chicago, Illinois.

Elizabeth Funk (E)

Cancer Research Program, American College of Surgeons, Chicago, Illinois.

Heidi Nelson (H)

Cancer Research Program, American College of Surgeons, Chicago, Illinois.
Commission on Cancer, American College of Surgeons, Chicago, Illinois.
Department of Surgery, Mayo Clinic, Rochester, Minnesota.

David R Freyer (DR)

Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles.
USC Norris Comprehensive Cancer Center, Los Angeles, California.
Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles.
Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH